Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Double-blind Placebo-controlled Parallel Group Study Evaluating Paliperidone Palmitate in the Prevention of Recurrence in Patients With Schizophrenia. Placebo Consists of 20% Intralipid (200 mg/mL) Injectable Emulsion.
Brief Summary: The purpose of this study is to evaluate the efficacy of paliperidone palmitate compared with placebo in the prevention of recurrence of the symptoms of schizophrenia and to assess the safety and tolerability of paliperidone palmitate in patients with stable and symptomatic schizophrenia. The placebo used in this study was a nutritional substance known as 20% Intralipid emulsion given to patients requiring intravenous feedings.


Options:
A: Arm Label: Aripiprazole depot; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole depot | Arm Label: Placebo depot; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo depot | Intervention Type: DRUG; Name: Aripiprazole depot; Assigned to Arm(s): Aripiprazole depot | Intervention Type: DRUG; Name: Placebo depot; Assigned to Arm(s): Placebo depot
B: Intervention Type: PROCEDURE; Name: dosing; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Drug: Olanzapine, Drug: Amisulpride, Drug: Risperidone, Drug: Haloperidol, Drug: Quetiapine, Drug: Perphenazine, Drug: Sulpiride, Drug: bromperidol, Drug: Zuclopenthixol, Drug: Thioridazine, Drug: Paliperidone, Drug: Ziprasidone, Drug: Benperidol, Drug: Fluspirilene, Drug: Pimozide, Drug: Perazine, Drug: Fluphenazine, Drug: Flupentixole, Drug: Sertindole | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olanzapine, Drug: Amisulpride, Drug: Risperidone, Drug: Haloperidol, Drug: Quetiapine, Drug: Perphenazine, Drug: Sulpiride, Drug: bromperidol, Drug: Zuclopenthixol, Drug: Thioridazine, Drug: Paliperidone, Drug: Ziprasidone, Drug: Benperidol, Drug: Fluspirilene, Drug: Pimozide, Drug: Perazine, Drug: Fluphenazine, Drug: Flupentixole, Drug: Sertindole | Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Amisulpride; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Haloperidol; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Perphenazine; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Sulpiride; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: bromperidol; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Zuclopenthixol; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Thioridazine; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Paliperidone; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Ziprasidone; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Benperidol; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Fluspirilene; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Pimozide; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Perazine; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Fluphenazine; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Flupentixole; Assigned to Arm(s): Control, Intervention | Intervention Type: DRUG; Name: Sertindole; Assigned to Arm(s): Control, Intervention
D: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: Paliperidone Palmitate | Arm Label: 002; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: Paliperidone Palmitate; Assigned to Arm(s): 001

Answer: D